Literature DB >> 12515707

No radiation protection reasons for restrictions on 14C urea breath tests in children.

M Gunnarsson1, S Leide-Svegborn, K Stenström, G Skog, L-E Nilsson, R Hellborg, S Mattsson.   

Abstract

Traditional (14)C urea breath tests are normally not used for younger children because the radiation exposure is unknown. High sensitivity accelerator mass spectrometry and an ultra-low amount (440 Bq) of (14)C urea were therefore used both to diagnose Helicobacter pylori (HP) infection in seven children, aged 3-6 years, and to make radiation dose estimates. The activity used was 125 times lower than the amount normally used for older children and 250 times lower than that used for adults. Results were compared with previously reported biokinetic and dosimetric data for adults and older children aged 7-14 years. (14)C activity concentrations in urine and exhaled air per unit administered activity for younger children (3-6 years) correspond well with those for older children (7-14 years). For a child aged 3-6 years who is HP negative, the urinary bladder wall receives the highest absorbed dose, 0.3 mGy MBq(-1). The effective dose is 0.1 mSv MBq(-1) for the 3-year-old child and 0.07 mSv MBq(-1) for the 6-year-old child. For two children, the 10 min and 20 min post-(14)C administration samples of exhaled air showed a significantly higher amount of (14)C activity than for the rest of the children, that is 6% and 19% of administered activity exhaled per hour compared with 0.3-0.9% (mean 0.5%) of administered activity exhaled per hour indicating that these two children that is were HP positive. For a 3-year-old HP positive child, absorbed dose to the urinary bladder wall was 0.3 mGy MBq(-1) and effective dose per unit of administered activity was 0.4 mSv MBq(-1). Using 55 kBq, which is a normal amount for older children when liquid scintillation counters are used for measurement, the effective dose will be approximately 6 micro Sv to a 3-year-old HP negative child and 20 microSv to a HP positive child. Thus there is no reason for restrictions on performing a normal (14)C urea breath test, even on young children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12515707     DOI: 10.1259/bjr.75.900.750982

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

Review 1.  Accelerator mass spectrometry-enabled studies: current status and future prospects.

Authors:  Ali Arjomand
Journal:  Bioanalysis       Date:  2010-03       Impact factor: 2.681

Review 2.  Safety of 14C-UBT for diagnosis of Helicobacter pylori infection in pregnancy.

Authors:  Yedidia Bentur; Doreen Matsui; Gideon Koren
Journal:  Can Fam Physician       Date:  2009-05       Impact factor: 3.275

Review 3.  Quantifying exploratory low dose compounds in humans with AMS.

Authors:  Stephen R Dueker; Le T Vuong; Peter N Lohstroh; Jason A Giacomo; John S Vogel
Journal:  Adv Drug Deliv Rev       Date:  2010-10-31       Impact factor: 15.470

4.  Validity and cost comparison of 14carbon urea breath test for diagnosis of H Pylori in dyspeptic patients.

Authors:  Shahid Rasool; Shahab Abid; Wasim Jafri
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

Review 5.  Update on diagnostic value of breath test in gastrointestinal and liver diseases.

Authors:  Imran Siddiqui; Sibtain Ahmed; Shahab Abid
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

6.  Glimpse of the epidemiological research on Helicobacter pylori in Saudi Arabia.

Authors:  Abdulaziz A BinSaeed
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

7.  A microdose study of ¹⁴C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung.

Authors:  G Lappin; M J Boyce; T Matzow; S Lociuro; M Seymour; S J Warrington
Journal:  Eur J Clin Pharmacol       Date:  2013-06-06       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.